Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer

NCT01518621 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01518621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01518621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2012
Completion date
December 10, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer